Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function

Annals of Thoracic Surgery

Volumn 77, Issue 6, 2004, Pages 2122-2129

  Jayasankar, Vasant ^a   Bish, Lawrence T ^a   Pirolli, Timothy J ^a   Berry, Mark F ^a   Burdick, Jeffrey ^a   Woo, Y Joseph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

30

Indexed keywords

GROWTH HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEMODYNAMICS; HORMONE ACTION; HORMONE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE;

ADENOVIRIDAE; ANIMALS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMAN GROWTH HORMONE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, INBRED LEW; TRANSGENES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 2542458277     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.12.043     Document Type: Article

References (32)

1. American Heart Association. 2003 Heart disease and stroke statistical update. 2003;American Heart Association, Dallas, TX
2. White H.D., Norris R.M., Brown M.A., et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51
3. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction experimental observations and clinical implications. Circulation. 81:1990;161-172
4. Kostuk W.J., Kazamias T.M., Gander M.P., Simon A.L., Ross J. Jr. Left ventricular size after acute myocardial infarction serial changes and their prognostic significance. Circulation. 47:1973;1174-1179
5. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 327:1992;669-677
6. Teerlink J., Massie B. Beta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol. 84:1999;94R-102R
7. Dymond D.S., Stephens J.D., Stone D.L., Elliott A.T., Rees G.M., Spurrell R.A. Combined exercise, radionuclide and hemodynamic evaluation of left ventricular aneurysmectomy. Am Heart J. 104:1982;977-987
8. Kass D.A., Baughman K.L., Pak P.H., et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation. 91:1995;2314-2318
9. Hagege A.A., Desnos M., Fernandez F., et al. Clinical study of the effects of latissimus dorsi muscle flap stimulation after cardiomyoplasty. Circulation. 92:1995;210-215
10. Batista R.J.V., Santos J.L.V., Takeshita N., et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Cardiac Surg. 11:1996;96-97
11. Oh J.H., Badhwar V., Mott B.D., Li C.M., Chiu R.C. The effects of prosthetic cardiac binding and adynamic cardiomyoplasty in a model of dilated cardiomyopathy. J Thorac Cardiovasc Surg. 116:1998;148-153
12. Moainie S.L., Guy T.S., Gorman J.H., et al. Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after postero-lateral infarction. Ann Thorac Surg. 74:2002;444-449
13. Konertz W., Dushe S., Hotz H., et al. Safety and feasibility of a cardiac support device. J Card Surg. 16:2001;113-117
14. Adamafio N.A., Towns R.J., Kostyo J.L. Growth hormone receptors and action in BC3H-1 myocytes. Growth Regul. 1:1991;17-22
15. Tivesten A., Caidahl K., Kujacic V., et al. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Horm IGF Res. 11:2001;187-195
16. Tajima M., Weinberg E.O., Bartunek J., et al. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation. 99:1999;127-134
17. Yang R., Bunting S., Gillett N., Clark T., Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 92:1995;262-267
18. Jin H., Yang R., Lu H., et al. Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction. Growth Horm IGF Res. 12:2002;208-215
19. Melmed S., Jackson I., Kleinberg D., Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab. 83:1998;2646-2652
20. Fukuda I., Hizuka N., Murakami Y., et al. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med. 40:2001;987-992
21. Jackson B.M., Gorman J.H., Salgo I.S., et al. Border zone geometry increases wall stress after myocardial infarction contrast echocardiographic assessment. Am J Physiol Heart Circ Physiol. 284:2003;H475-479
22. Liu Y.-H., Yang X.-P., Nass O., Sabbah H.N., Peterson E., Carretero O.A. Chronic heart failure induced by coronary artery ligation in Lewis inbred rat. Am J Physiol. 272:1997;H722-727
23. Roskam W.G., Rougeon F. Molecular cloning and nucleotide sequence of the human growth hormone structural gene. Nucleic Acids Res. 7:1979;305-320
24. Feldman M.D., Erikson J.M., Mao Y., et al. Validation of a mouse conductance system to determine LV volume comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol. 279:2000;H1698-1707
25. Sacca L., Cittadini A., Fazio S. Growth hormone and the heart. Endocr Rev. 15:1994;555-573
26. Mathews L.S., Enberg B., Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem. 264:1989;9905-9910
27. Fazio S., Sabatini D., Capaldo B., et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 334:1996;809-814
28. Genth-Zotz S., Zotz R., Geil S., Viogtlander T., Meger J., Darius H. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Circulation. 99:1999;18-21
29. Spallarossa P., Rossettin P., Minuto F., et al. Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease. Am J Cardiol. 84:1999;430-433
30. Perrot A., Ranke M.B., Dietz R., Osterziel K.J. Growth hormone treatment in dilated cardiomyopathy. J Card Surg. 16:2001;127-131
31. Gilgenkrantz H., Duboc D., Juillard V., et al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors role of the immune response. Hum Gene Ther. 6:1995;1265-1274
32. Wong L.F., Wells S., Murphy D. Gene transfer strategies for the physiologist. Exp Physiol. 85:2000;735-745